Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Ashwagandha may help with skin and hair issues, but more research is needed.

Understanding sex and gender differences can improve personalized dermatology care.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Sarcoidosis can cause various skin issues, making diagnosis difficult.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Skin may help in getting rid of excess iron through the process of skin cell renewal.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Stem cells have great potential for improving wound healing, but more research is needed to find the best types and ways to use them.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Combining fractional CO2 laser with halometasone cream is more effective for chronic eczema than the cream alone.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.